Data as of 11:07am ET
| -1.02 / -2.63%|
The 5 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 43.00, with a high estimate of 50.00 and a low estimate of 29.00. The median estimate represents a +13.73% increase from the last price of 37.81.
The current consensus among 5 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.